Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A new strain of bird flu, known scientifically as highly pathogenic avian influenza (HPAI), has been confirmed in a duck farm in California. The World Organisation for Animal Health (WOAH) announced the detection of H5N9 earlier this week on its official website.
The outbreak also involves the more prevalent H5N1 strain, which was discovered at the same location in Merced County. This marks a significant concern for health officials and avian experts alike.
WOAH reported that this is the first confirmed case of HPAI H5N9 in U.S. poultry. Health agencies have launched extensive epidemiological investigations and enhanced surveillance measures following the outbreak.
According to David J. Cennimo, an associate professor of medicine and pediatrics at Rutgers New Jersey Medical School, the emergence of this new strain showcases the adaptability of influenza viruses. He emphasized that birds are highly susceptible to avian influenza, which can present in both mild and deadly forms.
The newly identified H5N9 strain appears to have origins in previous outbreaks, generally associated with less severe illnesses in avian populations. However, the ducks at the California farm have experienced severe morbidity and mortality.
Cennimo explained that genetic testing revealed a critical difference in the H5N9 strain from historical samples. This indicates that the current strain is a reassortment, a phenomenon where different influenza viruses exchange gene segments, creating new variants.
Reassortment occurs when two distinct influenza viruses infect the same host organism, allowing for a mix of gene features. Scientists have classified influenza viruses using the hemagglutinin (H) and neuraminidase (N) surface proteins. While H5N1 remains a primary focus, H5N9’s emergence raises questions about future risks.
Cennimo pointed out the significance of these mutations. Influenza vaccines are designed to match circulating strains, emphasizing the continual evolution within influenza virus types. This is why yearly predictions are crucial for vaccine deployment.
Cennimo further noted that the H5 in H5N9 originates from the currently circulating H5N1 strain, which is known for its high pathogenicity. He expressed concern that the N1 in H5N9 may have mutated, incorporating elements from another viral strain.
Experts continue to monitor human infections closely. As of now, there have been no reported human cases linked to H5N9. Cennimo reassured that health authorities will maintain vigilance in tracking any developments.
Dr. Jacob Glanville, CEO of the San Francisco-based biotechnology firm Centivax, discussed the role of birds as reservoirs for various influenza strains, many of which do not infect humans. He stated that researchers actively monitor these strains because they can evolve into pandemic threats.
Glanville noted that a large outbreak in a poultry farm not only jeopardizes the food supply but also increases the risk of mutations that might lead to spillover into mammals, further complicating public health concerns.
At present, reports indicate 67 confirmed cases of human infections related to bird flu across the United States, with one associated death, as recorded by the Centers for Disease Control and Prevention (CDC).
As experts express cautious optimism, they stress the importance of ongoing monitoring of emerging strains like H5N9. The evolving landscape of avian influenza poses continual challenges to both public health and agriculture.
With the increasing interconnectivity of global ecosystems, the vigilance of health officials and researchers remains paramount. Any potential shifts in virus behavior must be addressed promptly to mitigate the risk of widespread outbreaks.